tiprankstipranks
Advertisement
Advertisement

Airtasker Issues Unquoted Equity Securities Under Employee Incentive Scheme

Story Highlights
  • Airtasker has issued 3,569,886 unquoted options and rights under its employee incentive scheme.
  • The unquoted, restricted securities align staff rewards with Airtasker’s performance but may dilute shareholders later.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Airtasker Issues Unquoted Equity Securities Under Employee Incentive Scheme

Claim 30% Off TipRanks

An update from Airtasker Ltd ( (AU:ART) ) is now available.

Airtasker Limited has notified the market of the issue of 3,569,886 unquoted equity securities in the form of options and rights under its employee incentive scheme, with various exercise prices and expiry dates. These securities, which are subject to transfer restrictions and will not be quoted on the ASX until those restrictions end, reflect the company’s ongoing use of equity-based remuneration to incentivise and retain staff, potentially leading to future dilution for existing shareholders but aligning employee interests with long-term company performance.

The most recent analyst rating on (AU:ART) stock is a Sell with a A$0.20 price target. To see the full list of analyst forecasts on Airtasker Ltd stock, see the AU:ART Stock Forecast page.

More about Airtasker Ltd

Airtasker Limited is an Australian company listed on the ASX under the code ART. It operates an online marketplace platform that connects people and businesses with local taskers to outsource everyday tasks and services, positioning itself within the gig economy and digital services sector.

Average Trading Volume: 288,861

Technical Sentiment Signal: Sell

Current Market Cap: A$109.7M

See more insights into ART stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1